Table of Contents Table of Contents
Previous Page  35 / 916 Next Page
Show Menu
Previous Page 35 / 916 Next Page
Page Background

25th European Congress of Psychiatry / European Psychiatry 41S (2017) S8–S52


S.E. Setterberg

, E. Nissen , W. Jonas , M. Niemi

Karolinska Institute, Department of Reproductive Health, Stockholm,


Corresponding author.


Transition into parenthood is a demanding phase in

life and exposes the becoming parents to vulnerability for depres-

sion, anxiety and stress. Perinatal mental health problems are a

major public health issue and many women suffering from depres-

sion during their first year after delivery. High levels of stress during

pregnancy are associated with adverse psychological and physi-

ological outcomes for the infant and parents. There seems to be

an intergenerational transmission of mental health from parent to

infant. The current study evaluated the effectiveness ofmindfulness

intervention during pregnancy in reducing depression symptoms,

anxiety and perceived stress in parents-to-be.


Assess whether the mindfulness will improve interac-

tion between mother-infant at 12 months.


Perceived stress scale and Edinburgh postnatal depres-

sion scale used tomeasure stress and depression during pregnancy.

Parent child early relational assessment assessed mother-infant



Inhibited parent-infant relationships were more com-

mon in the control group comparing to the mindfulness

intervention group. This is in line with previous research on peri-

antal depression, anxiety, and stress, showing more dysfunctional

dyads. A depressed mother has reduced capability to be alert

to her baby’s signals, which is necessary for appropriate parent-

infant relationship to occur. The cumulative effect of impaired

parent-infant relationship is a “depressed dyad” of mother and



Mindfulness intervention reduced depressive symp-

toms, anxiety, and perceived stress in pregnant women. At 12

months mother-infant relationship assessment, the mindfulness

intervention group dyads showed a more attuned mother-infant


Disclosure of interest

The authors have not supplied their decla-

ration of competing interest.

Symposium: ICD-11 Classification of mental and

behavioural disorders–Recent developments


ICD-11: Example of psychotic


W. Gaebel

Heinrich-Heine-Universität Düsseldorf, Germany

The revision of the current classification criteria for disorders issued

by the World Health Organization (WHO) (International Classifi-

cation of Disorders, ICD-10) is underway and will also include a

revision of the classification criteria of the mental and behavioural

disorders. Working groups for specific groups of mental disor-

ders had produced suggestions for revised diagnostic criteria and

included a working group on schizophrenia and other primary

psychotic disorders. This presentation will focus on this group of

mental disorders. Major changes suggested were an introduction

of symptom and course specifiers, the inclusion of cognitive symp-

toms and a de-emphasising of the so-called first rank symptoms

of schizophrenia, a cross-sectional approach towards the classi-

fication of schizoaffective disorder and a reorganization of the

acute psychotic disorders. Initial internet-based field trials showed

some incremental improvements of diagnostic reliability, but more

crucial for an adjustment of the revised classification criteria will

be the expected results of the upcoming clinic-based field trials.

Disclosure of interest

Unterstützung bei Symposien/Symposia


– Janssen-Cilag GmbH, Neuss

– Aristo Pharma GmbH, Berlin

– Lilly Deutschland GmbH, Bad Homburg

– Servier Deutschland GmbH, München

– Fakultätsmitglied/Faculty Member

– Lundbeck International Neuroscience Foundation (LINF), Däne-



SM-5, ICD-11, RDoC and the future of

psychiatric classification

M. Maj

Department of Psychiatry, University of Largo Madonna delle Grazie,

80138 Naples, Italy

The publication of the DSM-III in 1980was intended to be a reaction

to the evidence of the embarrassingly low reliability of psychiatric

diagnoses, which was perceived as a major threat to the credibil-

ity of the psychiatric profession. The aims of the DSM-III project

were actually two. First, the reliable definition of the diagnos-

tic categories was expected to lead to the collection of research

data that would validate those diagnostic entities and in particu-

lar elucidate their etiopathogenetic underpinnings. Second, there

was an expectation that, by increasing reliability, communication

among clinicians would be improved and clinical decisions made

more rational. Today, one could say that the first aim of the project

has not been achieved, while the fulfilment of the second aim has

never been tested appropriately. The crisis of confidence in the DSM

paradigm, clearly emerging from the debate following the publica-

tion of the DSM-5, has led on the one hand to a renewed emphasis

on clinical utility, which is featuring prominently in the ongoing

process of development of the ICD-11. On the other hand, it has

led to a radical attempt to reform psychiatric nosology starting

from neurobiological and behavioural phenotypes. This attempt

does have its weaknesses, but may also represent a stimulus to

reconceptualize some psychopathological constructs, especially in

the area of psychoses, in order to reduce the gap between the level

of neuroscience and that of clinical phenomenology.

Disclosure of interest

The author has not supplied his declaration

of competing interest.

Symposium: Tobacco dependence and smoking

cessation in people with mental illness


PA Guidance paper on tobacco

dependence and smoking cessation

H.J. Möller

Ludwig Maximilians University, Munich, Germany

Tobacco dependence is the most common substance use disor-

der in adults with mental illness. The prevalence rates for tobacco

dependence are two to four times higher in these patients than

in the general population. Smoking has a strong, negative influ-

ence on the life expectancy and quality of life of mental health

patients, and remains the leading preventable cause of death in

this group. Despite these statistics, in some countries smokers